Skip to content

Drug interactions

Indacaterol + Verapamil

Severity: Minor

Indacaterol and Verapamil: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Verapamil inhibits P-glycoprotein and CYP3A4, both involved in indacaterol clearance, and raises indacaterol systemic exposure. The increase is modest and was not considered clinically important at the recommended inhaled dose. Higher exposure could in principle increase beta-agonist effects such as tachycardia and tremor.

What this interaction means in plain words

Indacaterol and Verapamil have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Indacaterol belongs to Respiratory; Verapamil belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Inhibition of P-glycoprotein and CYP3A4 by verapamil reduces systemic clearance of indacaterol.

What to do

No dose adjustment is needed at the recommended indacaterol dose. Monitor for tachycardia, tremor and hypokalemia if symptoms appear.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol and Verapamil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Indacaterol with Verapamil?

MediHelp rates the interaction as minor. Indacaterol and Verapamil have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Verapamil inhibits P-glycoprotein and CYP3A4, both involved in indacaterol clearance, and raises indacaterol systemic exposure. The increase is modest and was not considered clinically important at the recommended inhaled dose. Higher exposure could in principle increase beta-agonist effects such as tachycardia and tremor.

How serious is the interaction between Indacaterol and Verapamil?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed at the recommended indacaterol dose. Monitor for tachycardia, tremor and hypokalemia if symptoms appear.

What other medicines interact with Indacaterol?

MediHelp also lists interactions of Indacaterol with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Indacaterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in